glp 1 meds and alzheimer's GLP-1 Microdosing, Brain Health & Prevention A doctor explains why GLP-1

Recent Developments: As of mid-2026, the FDA has proposed to exclude popular GLP-1 substances like Semaglutide, Tirzepatide, and Liraglutide from the list, concluding that there is no clinical need to compound them from bulk ingredients when approved versions are available

Always review the full safety information that comes with your prescription and consult your prescriber or pharmacist with any questions

Over CNS, the direct action on NTS, hypothalamic arcuate and surrounding structures, as well as the effect on the ventral tegmental area and nucleus accumbens may act on homeostatic and hedonic hunger, changing palatability and reward behavior

doi: 10.1007/s001250050348 [DOI] [PubMed] [Google Scholar] 61

MEDVi, LLC , a federal Telephone Consumer Protection Act lawsuit filed in May 2025

Eligibility is broader than whats typically associated with GLP-1 prescriptions